262 related articles for article (PubMed ID: 15833857)
1. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
[TBL] [Abstract][Full Text] [Related]
2. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
Gilley J; Fried M
Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
[TBL] [Abstract][Full Text] [Related]
3. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor.
Tsubari M; Tiihonen E; Laiho M
Cancer Res; 1997 Jul; 57(14):2966-73. PubMed ID: 9230210
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus.
Robertson KD; Jones PA
Oncogene; 1999 Jul; 18(26):3810-20. PubMed ID: 10445844
[TBL] [Abstract][Full Text] [Related]
6. Rb independent inhibition of cell growth by p15(INK4B).
Aytac U; Konishi T; David H; Mendoza S; Miller CW
Biochem Biophys Res Commun; 1999 Aug; 262(2):534-8. PubMed ID: 10462509
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
[TBL] [Abstract][Full Text] [Related]
9. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
10. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
[TBL] [Abstract][Full Text] [Related]
12. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
[TBL] [Abstract][Full Text] [Related]
13. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
Weber HO; Samuel T; Rauch P; Funk JO
Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
[TBL] [Abstract][Full Text] [Related]
14. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
16. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Zindy F; Quelle DE; Roussel MF; Sherr CJ
Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
18. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
[TBL] [Abstract][Full Text] [Related]
20. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]